Healthy Volunteers Clinical Trial
Official title:
Collection of Blood, Bone Marrow, Skin Biopsies and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Laboratory Research Studies
Verified date | September 5, 2018 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- Laboratory research studies require control samples from healthy volunteers to compare with
samples from patients. These studies will help researchers better understand and refine
treatments for immune system and inflammatory diseases.
Objective:
- To obtain blood, urine, buccal (mouth) mucosa, normal tissue and bone marrow samples and/or
leukopheresis cells from healthy volunteers.
Eligibility:
- Healthy individuals at least 8 years of age.
Design:
- Volunteers will be recruited through the Program for Healthy Volunteers, Patient
Recruitment and Public Liaison Office, or self-referral through the clinicaltrials.gov
Web site.
- Health will be confirmed by a brief history and physical examination and blood work.
- Volunteers 8 years of age and older will provide blood and urine samples using standard
procedures. Buccal mucosa samples will be obtained by scraping the insides of both
cheeks with a sterile nylon brush.
- Bone marrow samples will be obtained from volunteers 18 years of age and older by taking
two aspirates from the posterior iliac crest (an area near the hip).
- Normal tissue samples will be obtained from volunteers 18 years of age and older by
taking superficial skin samples (punch biopsies)
- Leukopheresis or lymphapheresis will be performed on volunteers 18 years of age and
older to obtain white blood cells for research
- Samples will be assigned a unique code and will be stored until they are no longer of
scientific value or the volunteer withdraws consent for their use.
Status | Completed |
Enrollment | 88 |
Est. completion date | September 5, 2018 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years and older |
Eligibility |
- INCLUSION CRITERIA: - Healthy volunteer (health status confirmed by brief History and Physical Exam and blood work) - Age 8 years and older (no upper limit) for blood, urine, and buccal mucosa sampling Or Ages 18 years or older (no upper limit) for bone marrow or normal tissue sampling and/or leukapheresis cells Or Pregnant women (health status confirmed by brief History and Physical Exam and blood work) must be 18 years or older (no upper limit) for blood and/or buccal mucosa sampling - Able to comprehend the investigational nature of the protocol and provide informed consent (If the healthy volunteer is a minor, the minor s parent or guardian must provide consent and the minor must be able to provide assent) - Must be willing to allow samples to undergo genetic studies. EXCLUSION CRITERIA: - Healthy volunteers and/or pregnant women with diseases with an inflammatory or immune component - Subjects with active infections requiring systemic antibiotic therapy - Persons who are alcoholic or abusers of illicit substances |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mechanism for collecting samples | One time point |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT06236009 -
A First-In-Human Study of TAK-004 in Healthy Adults
|
Phase 1 |